logo

For the Inventor, By the Inventor

Grapevine, TX, United States of America

Robert M Kral, Jr

This inventor holds 10 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Reata Pharmaceuticals, Inc., Dartmouth College. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert M Kral, Jr. Retrieved from https://idiyas.com/inventor/robert-m-kral-jr-mdnaer5q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 90.0

 

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 363(Granted Patents)


Company Filing History:

goldMedal10 out of 64 
 
Reata Pharmaceuticals, Inc.
 patents
silverMedal4 out of 708 
 
Dartmouth College
 patents
where one patent can have more than one assignee

Years Active: 2012-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9796668 - Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use (2017-10-24),
2. 9757359 - Synthetic triterpenoids and methods of use in the treatment of disease (2017-09-12),
3. 9233998 - Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use (2016-01-12),
4. 8778990 - Betulinic acid derivatives and methods of use thereof (2014-07-15),
5. 8633243 - Forms of CDDO methyl ester (2014-01-21),
6. 8455544 - Synthetic triterpenoids and methods of use in the treatment of disease (2013-06-04),
7. 8309601 - Forms of CDDO methyl ester (2012-11-13),
8. 8258329 - Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use (2012-09-04),
9. 8129429 - Synthetic triterpenoids and methods of use in the treatment of disease (2012-03-06),
10. 8088824 - Forms of CDDO methyl ester (2012-01-03),

Title: Innovations and Contributions of Robert M Kral, Jr.

Introduction

Robert M Kral, Jr. is a notable inventor based in Grapevine, TX (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Kral has made strides in developing novel compounds and methods that address various health issues.

Latest Patents

Among his latest patents, Kral has developed natural product analogs that include an anti-inflammatory cyanoenone pharmacore. This invention provides novel compounds that comprise an anti-inflammatory pharmacore, along with pharmaceutical compositions, kits, and articles of manufacture that utilize these compounds. Additionally, he has worked on synthetic triterpenoids and methods for their use in treating diseases such as renal/kidney disease, insulin resistance/diabetes, fatty liver disease, and cardiovascular disease.

Career Highlights

Kral has had a distinguished career, working with reputable organizations such as Reata Pharmaceuticals, Inc. and Dartmouth College. His work has focused on innovative solutions that have the potential to improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Kral has collaborated with esteemed colleagues, including Michael B Sporn and Karen T Liby. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Robert M Kral, Jr. continues to be a driving force in the field of pharmaceutical innovation, with his patents reflecting a commitment to improving health through scientific advancements. His work exemplifies the impact of dedicated inventors in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…